Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
NFlection Therapeutics, Inc. See All Filings	D	2023-07-20 19:55:12 UTC
Amount To Be Raised $4,000,000 Associated Brokers / Dealers N/A CIK Number 0001694227 Filed Document 0001694227-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-07-20 19:55:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
NFlection Therapeutics, Inc. See All Filings	D/A	2022-06-21 11:50:19 UTC
Amount To Be Raised $30,000,000 Associated Brokers / Dealers N/A CIK Number 0001694227 Filed Document 0001694227-22-000003 Exclusions or Exemptions 506b Accepted Date 2022-06-21 11:50:19 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
NFlection Therapeutics, Inc. See All Filings	D	2022-06-09 18:30:59 UTC
Amount To Be Raised $20,000,000 Associated Brokers / Dealers N/A CIK Number 0001694227 Filed Document 0001694227-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-06-09 18:30:59 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
NFlection Therapeutics, Inc. See All Filings	D/A	2020-04-24 16:46:56 UTC
Amount To Be Raised $24,000,000 Associated Brokers / Dealers N/A CIK Number 0001694227 Filed Document 0001694227-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-04-24 16:46:56 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business PENNSYLVANIA Revenue or Assets Decline to Disclose Type of Security Equity
NFlection Therapeutics, Inc. See All Filings	D	2017-01-17 10:51:49 UTC
Amount To Be Raised $14,000,000 Associated Brokers / Dealers N/A CIK Number 0001694227 Filed Document 0001694227-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-01-17 10:51:49 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity